Table 1. In vitro activities of chromene-based chalcones 25–29 and 30–34 against the promastigote form of L. major.
| |||||
|---|---|---|---|---|---|
| Compound | R | % inhibition at the concentration of 10a μM | |||
| Day 1 | Day 2 | Day 3 | IC50b (μM) | ||
| 25 | H | 0.0 | 18.8 | 93 | 30 ± 0.06 |
| 26 | 2-Cl | 100 | 100 | 100 | 5 ± 0.14 |
| 27 | 3-Cl | 100 | 100 | 100 | 0.8 ± 0.26 |
| 28 | 4-Cl | 100 | 100 | 100 | 0.7 ± 0.3 |
| 29 | 2,4-Cl2 | 98.1 | 100 | 100 | 0.75± 0.23 |
| 30 | H | 0.0 | 12.8 | 62.8 | 45 ± 0.15 |
| 31 | 2-Cl | 0.0 | 0.0 | 1.0 | >50 |
| 32 | 3-Cl | 0.0 | 0.0 | 75.2 | 45 ± 0.22 |
| 33 | 4-Cl | 0.0 | 0.0 | 5.4 | >50 |
| 34 | 2,4-Cl2 | 4.3 | 4.3 | 8.4 | >50 |
| Glucantime | 81.97 ± 3.85c | ||||
The growth inhibitory effect of compounds on Leishmania parasite for three consecutive days.
The values represent mean ± SD,
IC50 in mM.